Ohio Gov. Mike DeWine announces appointment to UC Board of Trustees
March 29, 2024
Ohio Governor Mike DeWine appoints Kerry Byrne as University of Cincinnati Board of Trustee member effective March 4, 2024 through January 2033.
March 29, 2024
Ohio Governor Mike DeWine appoints Kerry Byrne as University of Cincinnati Board of Trustee member effective March 4, 2024 through January 2033.
March 28, 2024
While navigating the intricacies of pioneering research initiatives, faculty and student innovators can stay current on legal safeguards and protect invention commercialization through the University of Cincinnati’s tech transfer team in the 1819 Innovation Hub.
March 28, 2024
UC's popular Biology Meets Engineering program introduces high school students to STEM. Now, the National Science Foundation is paying UC to bring the program to three other Ohio universities.
March 28, 2024
Two Cincinnati Law faculty members were recognized for their scholarly body of work.
March 28, 2024
Two UC Law professors were honored with university-wide awards.
March 28, 2024
At the University of Cincinnati's 1819 Innovation Hub, the doors to creativity are open wider through the cutting-edge podcast recording studio, now available to all UC affiliates at zero cost.
March 27, 2024
The University of Cincinnati College-Conservatory of Music Philharmonia takes the stage with an exciting program of all Spanish-inspired music on Friday, March 29 at 7:30 p.m. in CCM’s Corbett Auditorium. Tickets are on sale now through the CCM Box Office.
March 26, 2024
The University of Cincinnati's Ed Faber spoke with EveryDay Health about ways to manage symptoms of multiple myeloma including numbness, pain or tingling in your arms and legs.
March 26, 2024
Ohio Voices, a video segment produced by Spectrum News, paid a visit to the University of Cincinnati to lift the voices of students, staff and faculty. Nine Bearcats were featured in the recent segment.
March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.